Miller Wealth Advisors’s Pfizer PFE Stock Holding History

Miller Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.7K	Buy	396 +296	+296%	+$7.74K	0.02%	40
2026 Q1	$2.81K	Hold	100	–	–	﹤0.01%	95
2025 Q4	$2.49K	Hold	100	–	–	﹤0.01%	104
2025 Q3	$2.55K	Hold	100	–	–	﹤0.01%	94
2025 Q2	$2.42K	Hold	100	–	–	﹤0.01%	85
2025 Q1	$2.53K	Hold	100	–	–	﹤0.01%	80
2024 Q4	$2.65K	Hold	100	–	–	﹤0.01%	74
2024 Q3	$2.93K	Hold	100	–	–	﹤0.01%	71
2024 Q2	$2.8K	Hold	100	–	–	﹤0.01%	69
2024 Q1	$2.77K	Hold	100	–	–	﹤0.01%	69
2023 Q4	$2.88K	Hold	100	–	–	﹤0.01%	67
2023 Q3	$3.32K	Hold	100	–	–	﹤0.01%	63
2023 Q2	$3.67K	Buy	+100	New	+$3.89K	﹤0.01%	62
2023 Q1	–	Sell	-100	Closed	-$4.32K	–	72
2022 Q4	$5K	Hold	100	–	–	﹤0.01%	61
2022 Q3	$5K	Hold	100	–	–	﹤0.01%	74
2022 Q2	$5K	Hold	100	–	–	﹤0.01%	66
2022 Q1	$5K	Hold	100	–	–	﹤0.01%	73
2021 Q4	$6K	Buy	+100	New	+$4.96K	﹤0.01%	70

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Miller Wealth Advisors's PFE Position: Q2 2026 in Review

Miller Wealth Advisors increased its Pfizer (PFE) stake by 296% in Q2 2026, buying an estimated $7.74K and bringing the position to 396 shares worth $42.7K. The position accounts for 0.02% of the portfolio, ranked #40.

Miller Wealth Advisors first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. 1,090 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Miller Wealth Advisors held 396 shares of Pfizer worth $42.7K as of Q2 2026.
Miller Wealth Advisors bought 296 Pfizer shares in Q2 2026, an estimated $7.74K.
Pfizer made up 0.02% of Miller Wealth Advisors's portfolio in Q2 2026, its #40 holding.
Miller Wealth Advisors first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
1,090 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Miller Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.